. 2021 Jun 10;7(6):e07265. doi: 10.1016/j.heliyon.2021.e07265

Table 3.

In-vitro antifungal studies of synthesized ZnO nanoparticles.

S No	Fungi	Zinc oxide Nanoparticles Zone of inhibition (mm)
S No	Fungi	170 ± 2 ppm	100 ± 1 ppm	50 ± 1 ppm
1	Meyerozyma caribbica	2.9 ± 0.12^b	2.5 ± 0.08^cd	2.3 ± 0.02^ab
2	Aspergillus niger	2.7 ± 0.14^c	2.1 ± 0.22^c	2.0 ± 0.05^a
3	Meyerozyma guilliermondii	2.5 ± 0.05^b	2.3 ± 0.14^d	2.0 ± 0.07^a
4	Rhizopus oryzae	2.9 ± 0.08^a	2.2 ± 0.02^ab	1.9 ± 0.08^c
5	Aspergillus flavus	2.7 ± 0.06^a	1.9 ± 0.08^ab	1.7 ± 0.06^a
6	Aspergillus oryzae	2.5 ± 0.04^c	1.5 ± 0.06^c	1.3 ± 0.04^a
7	Trichoderma asperellum	2.7 ± 0.08^a	1.6 ± 0.05^a	1.4 ± 0.12^b
8	Fusarium oxysporium	2.1 ± 0.02^a	1.9 ± 0.04^d	1.7 ± 0.14^c
	C.R.D (P < 0.05) The data	0.27	0.23	0.22

The data presented is ± SE of three measurements.

Data followed by the same letter are not significantly different at P ≤ 0.05, whereas those followed by different letters are significantly different at P ≤ 0.05.